The Future of Melanoma: What to Anticipate in 2022
With Anthony J. Olszanski, MD, RPh and Jeffrey M. Farma, MD, FACS, co-directors of Fox Chase Cancer Center’s Melanoma and Skin Cancer Program.
Drs. Farma and Olszanski will discuss:
- new surgical and systemic options for the treatment of patients with melanoma;
- the role of neoadjuvant therapy prior to surgery;
- how it is determined which patients are considered for neoadjuvant therapy;
- two case studies
"I believe that the path towards treating any disease is best navigated by thoroughly understanding not only the disease, but also the patient. Good communication between a physician and a patient is especially critical in the treatment of cancer. Each patient has a right to be both respected and heard. In addition, relying on a team of experts to help manage the complexities of treating cancer is essential for success. As a physician, I strive to provide personalized and scientifically sound care to each of my patients." Anthony J. Olszanski, MD, RP
"For melanoma and sarcoma that has regional spread in the extremities, I offer a minimally invasive technique called Isolated Limb Infusion and perform minimally invasive inguinal lymph node dissections. Most importantly, I hold my patients as my number one priority. I will spend as much time as necessary educating, answering questions, and providing guidance for each individual patient to help them throughout each stage of treatment. I believe in candid discussions, where both the patients' and families' goals and expectations are openly communicated. We will work together as a team to formulate a treatment plan. My personal goal is to treat and care for every patient with the same compassion and honesty as if they were a friend or family member." Jeffrey M. Farma, MD, FACS
